AnalystsAndy ChenAndy Chen's Stock Forecasts
AnalystsAndy Chen
Sectors:
Industries:
Analyst Ranking
Top 22%
#1090 out of 4922 analysts
Average Return
+24.33%
Win Rate
35%6 out of 17
Risk vs Reward
Poor
Good
Andy Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | +546.47% | $10.05 | $64.97 | 2023-10-18 - 2024-05-17 | Strong Buy |
Insmed IncINSM | +175.86% | $28.75 | $79.31 | 2024-02-15 - 2025-02-14 | Buy |
Zenas Biopharma IncZBIO | +25.07% | $7.66 | $9.58 | 2025-02-04 - 2025-06-27 | Buy |
Moonlake ImmunotherapeuticsMLTX | +21.22% | $39.20 | $47.52 | 2025-05-19 - 2025-06-27 | Buy |
Intellia Therapeutics IncNTLA | +20.71% | $7.92 | $9.56 | 2025-04-21 - 2025-06-27 | Buy |
Andy Chen Analyst Color
Get additional color on Andy Chen's coverage of popular stocks
Andy Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bridgebio Pharma IncBBIO | 1 | Buy | $49.00 | +9.23% | Initiates Coverage On | 14 days ago |
Avidity Biosciences IncRNA | 1 | Buy | $55.00 | +89.46% | Initiates Coverage On | 14 days ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Buy | $61.00 | +28.37% | Upgrades | a month ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $21.00 | +119.67% | Upgrades | 2 months ago |
Oruka Therapeutics IncORKA | 1 | Buy | $20.00 | +80.51% | Initiates Coverage On | 5 months ago |
Vera Therapeutics IncVERA | 1 | Buy | $49.00 | +116.34% | Initiates Coverage On | 5 months ago |
Zenas Biopharma IncZBIO | 1 | Buy | $19.00 | +98.33% | Initiates Coverage On | 5 months ago |
Argenx SeARGX | 1 | Buy | $697.00 | +24.43% | Upgrades | 8 months ago |
Celldex Therapeutics IncCLDX | 1 | Buy | $51.00 | +151.36% | Reiterates | 9 months ago |
Kymera Therapeutics IncKYMR | 1 | Buy | $65.00 | +47.33% | Upgrades | 10 months ago |
Roivant Sciences LtdROIV | 1 | Buy | $17.00 | N/A | Initiates Coverage On | a year ago |
Immunovant IncIMVT | 1 | Buy | $55.00 | N/A | Initiates Coverage On | a year ago |
Insmed IncINSM | 1 | Buy | $42.00 | N/A | Initiates Coverage On | a year ago |
Rapt Therapeutics IncRAPT | 2 | Buy | $312.00 | N/A | Initiates Coverage On | a year ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Affimed NvAFMDQ | 1 | Strong Buy | $60.00 | N/A | Assumes | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.